日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinction of IgG4-related mastitis from breast cancer: a case report

IgG4相关性乳腺炎与乳腺癌的鉴别诊断:病例报告

Tsuda, Banri; Kumaki, Nobue; Ishida, Rie; Mizuno, Mari; Yokoyama, Kozue; Oshitanai, Risa; Terao, Mayako; Morioka, Toru; Okamura, Takuho; Saito, Yuki; Suzuki, Yasuhiro; Niikura, Naoki

B-cell populations are expanded in breast cancer patients compared with healthy controls.

与健康对照组相比,乳腺癌患者的B细胞数量增加

Tsuda Banri, Miyamoto Asuka, Yokoyama Kozue, Ogiya Rin, Oshitanai Risa, Terao Mayako, Morioka Toru, Niikura Naoki, Okamura Takuho, Miyako Hirohito, Saito Yuki, Suzuki Yasuhiro, Kametani Yoshie, Tokuda Yutaka

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

乳腺癌患者原发肿瘤与脑转移瘤免疫微环境的比较

Ogiya, Rin; Niikura, Naoki; Kumaki, Nobue; Yasojima, Hiroyuki; Iwasa, Tsutomu; Kanbayashi, Chizuko; Oshitanai, Risa; Tsuneizumi, Michiko; Watanabe, Ken-Ichi; Matsui, Akira; Fujisawa, Tomomi; Saji, Shigehira; Masuda, Norikazu; Tokuda, Yutaka; Iwata, Hiroji

Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients

乳腺癌患者原发性肿瘤和转移性肿瘤中肿瘤浸润淋巴细胞的比较

Ogiya, Rin; Niikura, Naoki; Kumaki, Nobue; Bianchini, Giampaolo; Kitano, Shigehisa; Iwamoto, Takayuki; Hayashi, Naoki; Yokoyama, Kozue; Oshitanai, Risa; Terao, Mayako; Morioka, Toru; Tsuda, Banri; Okamura, Takuho; Saito, Yuki; Suzuki, Yasuhiro; Tokuda, Yutaka

Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab

S-1 在无法手术或复发性乳腺癌患者中的上市后安全性评估:尤其是在接受 S-1 + 曲妥珠单抗治疗的患者中

Saito, Yuki; Oshitanai, Risa; Terao, Mayako; Terada, Mizuho; Tsuda, Banri; Okamura, Takuho; Suzuki, Yasuhiro; Tokuda, Yutaka